I spoke at length with a representative of Peregrine in late December 2014. They told me the major partner at the table is waiting for interim results of the melanoma trial and they are waiting on the first look in milestone of the Sunrise trial before the deal can be consummated.
If anyone had actually said what you said they said, that person would have been guilty of a major breach of SEC Reg FD.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”